Inflammatory Breast Cancer (IBC)
1 clinical trials · Condition
◉ Watch Inflammatory Breast Cancer (IBC)
| Record | Firm | Date |
|---|---|---|
| Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer (NCT02876302) | Dana-Farber Cancer Institute | 2018-01-24 |
Track Inflammatory Breast Cancer (IBC) automatically
Every clearance here is in the API, with alerts when new ones post.